Pages that link to "Q44615998"

The following pages link to Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials (Q44615998):

Displaying 22 items.

• Bivalirudin: an anticoagulant option for percutaneous coronary intervention (Q28168650) (← links)
• Bivalirudin in percutaneous coronary intervention (Q28219409) (← links)
• Diagnosis and management of heparin-induced thrombocytopenia (Q33365985) (← links)
• Bivalirudin: a review of its use in patients undergoing percutaneous coronary intervention (Q33368029) (← links)
• Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options (Q33369119) (← links)
• Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia (Q33378823) (← links)
• Direct thrombin inhibitors: pharmacology and application in intensive care medicine (Q33389326) (← links)
• Direct thrombin inhibitors. (Q33393692) (← links)
• Is there attenuation of benefit of invasive therapy in patients with chronic kidney disease? Results from randomized trials and registry data (Q34283808) (← links)
• Anticoagulant drugs: an update (Q35821887) (← links)
• Percutaneous coronary intervention-related bleeding risk factors in current practice (Q36250196) (← links)
• Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials (Q36443751) (← links)
• Acute coronary syndromes in patients with renal disease: what are the issues? (Q36527848) (← links)
• Chronic kidney disease in acute coronary syndromes (Q37195393) (← links)
• Incidence of bleeding in renally impaired patients receiving incorrectly dosed eptifibatide or bivalirudin while undergoing percutaneous coronary intervention (Q37968583) (← links)
• Direct thrombin inhibitors in cardiovascular disease (Q38006641) (← links)
• Renal function and outcomes in acute coronary syndrome: impact of clopidogrel (Q44669077) (← links)
• Bias in AJHP supplements (Q46217385) (← links)
• Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function. (Q46644200) (← links)
• The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium. (Q48112185) (← links)
• Renal Dysfunction: How to Think About That in Acute Coronary Syndromes. (Q51822693) (← links)
• The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite (Q90005452) (← links)